Cambridge Healthtech Institute's Second Annual

Biocatalysis and Bio-Based Chemical Production

( 活体触媒与生物基础的化学产品制造 )

Biocatalysis, Enzyme and Metabolic Engineering, and Synthetic Biology

2018年1月9日 - 10日 | Hilton San Diego Bayfront | San Diego, CA


Advances in protein engineering, the advent of new chemistries and custom-made biocatalysis are leading to broader industrial enzyme across a range of industries, including pharma, fine chemicals and agriculture. Coupled with advances in systems and synthetic biology, the opportunities to create sustainable, scalable and cost-effective chemical production are greater than ever.

Cambridge Healthtech Institute's Second Annual Biocatalysis and Bio-Based Chemical Production conference tackles the latest technical and industrial advances in biocatalysis, enzyme engineering and synthetic biology, with dedicated sessions on new chemistries, protein engineering and novel applications of enzymes across a range of industries.

Preliminary Agenda

New Advances in Biocatalysis

What's New in Biocatalysis

David Rozzell, Ph.D., Senior Vice President, Biocatalysis, Provivi

The Discovery of a New Enzyme 'Reductive Aminase'

Nicholas Turner, Ph.D., Professor, Chemical Biology, University of Manchester

Computational Design: From Novel Enzymes to de novo Pathways and Designer Strains

Alexandre Zanghellini, Ph.D., CEO, Arzeda

Bioinformatics and Machine Learning Methods to Accelerate Enzyme Engineering

James Lalonde, Ph.D., Senior Vice President, R&D, Codexis

Computation Design of Enzymes and Machine Learning

Justin Siegel, Ph.D., Assistant Professor, Department of Chemistry, University of California, Davis

Industrial Application of Biocatalysis and Enzyme Engineering

Industrializing Biocatalysis - GSK Case Study

Doug Fuerst, Ph.D., Director, Technology Development Leader, Synthetic Biology, GSK

Biocatalysis: An Enabling Technology for Rapid Chemical Process Development

Jake Janey, Ph.D., Associate Director, BMS

(Meta)genome Mining: Closing the Discovery Loop from DNA to Compounds

Charles Moore, Ph.D., Laboratory Head, Novartis

Enzyme Engineering for Regioselective Hydroxylation in a Whole Cell Environment

Toni Lee, Ph.D., Senior Scientist, Biocatalysis, Provivi

Strain, Enzyme and Metabolic Engineering

Genome-Scale Engineering: A New Frontier in Metabolic Engineering

Huiman Zhao, Ph.D., Departments of Chemical and Biomolecular Engineering, Chemistry, and Biochemistry, Bioengineering, Institute for Genomic Biology, and Center for Biophysics and Computational Biology, University of Illinois

Engineering Cofactor Selectivity: Some New Ideas for an Old Problem

Scott Banta, Ph.D., Professor, Chemical Engineering, Columbia University

Combining Genome-Scale Modeling and Adaptive Laboratory Evolution to Optimize Enzymes and Whole Cells

Adam Feist, Ph.D., Project Scientist, Systems Biology Research Group, University of California

* 活动内容有可能不事先告知作更动及调整。